Clinical documentation review

Your clinical documentation may be AI-assisted.
The signature is still yours.

Independent clinical documentation review before you sign.
Always free for individual providers.
See a live demo →For organizations →
Why Vaultus exists

AI scribes can generate excellent documentation. EHRs store it. Neither independently reviews the note in the moment before you sign — and you remain accountable for the final record. Vaultus performs that independent review.

What Vaultus does

It reviews the note and surfaces what deserves a second look.

Patient safety

High-risk medication and dosing concerns.

Documentation integrity

Gaps and inconsistencies in the record.

Clinical closure

Results or findings not yet addressed.

Ownership

What the note claims versus what you’ve confirmed.

These are observations — not treatment recommendations.
Reviewmirtazapine + sertraline
The plan documents sertraline and mirtazapine together.
Review before signing
→ an example observation — click it
Why Vaultus is different

Your note may be AI-assisted. The review is not.

Vaultus does not use AI to review your note. It is an independent clinical documentation review based on national guidelines — applied the same way, every time. Not a second opinion from another model.

Vaultus is not
  • an AI scribe
  • an EHR
  • a second AI opinion
  • a medical decision-maker
Vaultus is

An independent clinical documentation review at the point of signature, based on national guidelines — consistent and repeatable. It does not guess.

How it works
1

Paste

Drop in the note.

2

Verify

Vaultus reviews it.

3

Review

See what deserves a look.

4

Sign

Sign with confidence.

Built to be trusted
Independent clinical documentation review National guideline-based review Continuously updated clinical knowledge You remain the final decision-maker HIPAA compliant
Take another look — mirtazapine + sertraline
Observation
The plan documents sertraline and mirtazapine together.
Clinical significance
Both medications have serotonergic activity. Combined use may increase risk for serotonin toxicity.
Documentation consideration
If this pairing is intentional, the note may not yet reflect the reasoning behind it.
Before signing
Review for clinical appropriateness and documentation completeness.
Authority ▾
FDA labeling